KNIAUDIŠKIŲ ŠEIMOS KLINIKA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,110,682 | 1,377,470 | 1,352,147 | 1,502,118 | 1,737,502 | 1,897,809 | 2,169,657 | 2,454,284 |
| Profit before tax | 163,724 | 372,836 | 206,439 | 154,125 | 260,087 | 194,263 | 278,261 | 494,368 |
| Net profit | 163,592 | 371,516 | 205,717 | 153,262 | 259,154 | 193,453 | 277,285 | 469,764 |
| Equity | 927,523 | 1,217,243 | 1,322,960 | 1,376,222 | 1,535,376 | 1,317,065 | 947,291 | 769,996 |
| Liabilities | 88,775 | 98,183 | 112,877 | 137,866 | 154,480 | 192,421 | 197,297 | 237,490 |
| Non-current assets | 382,734 | 430,090 | 571,743 | 527,219 | 492,420 | 451,946 | 448,286 | 286,765 |
| Current assets | 630,855 | 911,425 | 924,959 | 1,039,346 | 1,241,483 | 1,086,908 | 707,967 | 756,118 |
| Total assets | 1,013,589 | 1,341,515 | 1,496,702 | 1,566,565 | 1,733,903 | 1,538,854 | 1,156,253 | 1,042,883 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 325,885 | 406,927 | 416,604 |
| Social insurance contributions | - | - | - | - | - | 302,636 | 346,022 | 359,736 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +15.5% | +24.0% | -1.8% | +11.1% | +15.7% | +9.2% | +14.3% | +13.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 16.1% | 27.7% | 13.7% | 9.8% | 14.9% | 12.6% | 24.0% | 45.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 17.6% | 30.5% | 15.5% | 11.1% | 16.9% | 14.7% | 29.3% | 61.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 14.7% | 27.0% | 15.2% | 10.2% | 14.9% | 10.2% | 12.8% | 19.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 14.7% | 27.1% | 15.3% | 10.3% | 15.0% | 10.2% | 12.8% | 20.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 26,392 | 31,972 | 33,046 | 34,269 | 39,866 | 43,051 | 48,574 | 55,569 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
KNIAUDIŠKIŲ ŠEIMOS KLINIKA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-20 | 0.07 |
| 2025-02-10 | 2025-02-10 | 0.03 |
| 2025-01-22 | 2025-02-05 | 0.03 |
| 2024-12-17 | 2024-12-17 | 51.00 |
KNIAUDIŠKIŲ ŠEIMOS KLINIKA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
In 2025, KNIAUDIŠKIU ŠEIMOS KLINIKA, UAB (company code 148231352), a Private Limited Liability Company engaged in general medical practice activities, continued to expand its business. Revenue increased to €2.45M, up from €2.17M in 2024 and €1.90M in 2023, showing steady growth over the three-year period. Net profit rose to €469.8K in 2025 from €277.3K a year earlier and €193.5K in 2023. Profitability also improved, with the net profit margin reaching 19.1% in 2025 versus 12.8% in 2024 and 10.2% in 2023. The balance sheet remained solid, although equity declined to €770.0K from €947.3K in 2024 and total assets decreased to €1.04M from €1.16M. Liabilities increased to €237.5K. Key efficiency and leverage indicators were strong in 2025, including a debt-to-equity ratio of 0.31, an asset turnover ratio of 2.35x, ROE of 61.0%, and ROA of 45.0%. Revenue per employee stood at €55.8K, with profit per employee at €10.7K.